Lloyds TSB Bank PLC 38ZT Publication of Supplementary Prospectus

  Lloyds TSB Bank PLC (38ZT) - Publication of Supplementary Prospectus

RNS Number : 1595R
Lloyds TSB Bank PLC
14 November 2012
 



                                                              14 November 2012

 

Publication of Supplementary Prospectus

The following Supplementary  Prospectus has  been approved by  the UK  Listing 
Authority and is available for viewing:

Supplementary  Prospectus   dated  14   November  2012   (the   "Supplementary 
Prospectus") relating to the £50,000,000,000  Euro Medium Term Note  Programme 
of Lloyds TSB Bank plc

The Supplementary Prospectus should be read and construed in conjunction  with 
the base prospectus dated  20 April 2012, as  supplemented by a  supplementary 
prospectus dated 11 May  2012 and a supplementary  prospectus dated 28  August 
2012 (the "Base Prospectus").

To view the Supplementary Prospectus, please paste the following URL into  the 
address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/1595R_-2012-11-14.pdf

 

The Supplementary  Prospectus  has  been submitted  to  the  National  Storage 
Mechanism   and    will   shortly    be   available    for   inspection    at: 
www.Hemscott.com/nsm.do.

For further information, please contact

Nicole Sharp
Media Relations
Tel:       +44 20 7369 2120
Email:   nicole.sharp@lloydsbanking.com

Investor Relations:

Charles King

Director of Investor Relations

Tel:      +44 20 7356 3537

Email:  charles.king@ltsb-finance.co.uk

Frederik Verpoest
Director of Investor Relations
Tel:      +44 20 7356 2385
Email:  frederik.verpoest@ltsb-finance.co.uk

Lloyds TSB Bank plc
Registered Office
25 Gresham Street
London
EC2V 7HN

DISCLAIMER - INTENDED ADDRESSEES

Please note  that  the information  contained  in this  announcement  and  the 
Supplementary Prospectus may be  addressed to and/or  targeted at persons  who 
are  residents  of  particular  countries  (specified  in  the   Supplementary 
Prospectus) only and is not intended for use and should not be relied upon  by 
any person outside these  countries and/or to whom  this announcement and  the 
Supplementary  Prospectus  are  not  addressed.   Prior  to  relying  on   the 
information contained in this  announcement and the Supplementary  Prospectus, 
you must ascertain from  the Supplementary Prospectus whether  or not you  are 
one  of  the  intended  addressees  of  the  information  contained  in   this 
announcement and the Supplementary Prospectus.

In particular,  this  announcement and  the  Supplementary Prospectus  do  not 
constitute an offer or invitation to subscribe for, or purchase, securities in
the United  States  or  in any  other  jurisdiction  where such  an  offer  or 
invitation  would  be  unlawful.  This  announcement  and  the   Supplementary 
Prospectus are  not  for distribution in  the United  States.  The  securities 
described herein have  not been, and  will not be,  registered under the  U.S. 
Securities Act  of 1933,  as  amended (the  "Securities  Act"), or  under  any 
relevant securities laws of any state of the United States of America and  are 
subject to  U.S. tax  law  requirements. Subject  to certain  exceptions,  the 
securities may not be offered or sold  within the United States or to, or  for 
the account or benefit of, U.S. persons or to persons within the United States
of America, as  such terms are  defined in Regulation  S under the  Securities 
Act. There will be no public offering of the securities in the United  States. 
For a description of  the restrictions on offers  and sales of the  securities 
described herein,  please  refer  to the  Supplementary  Prospectus  and  Base 
Prospectus.

Your right to access this service is conditional upon complying with the above
requirement.

 

                     This information is provided by RNS
           The company news service from the London Stock Exchange
 
END
 
 
PDIGGGBUGUPPGMC -0- Nov/14/2012 17:12 GMT